Rapid Evaluation of Treatments for COVID-19: Adaptive COVID-19 Treatment Trial (ACTT)
The FHI Clinical team is thrilled to support the development of multiple COVID-19 therapies that offer patients safe, effective treatment options during the ongoing pandemic and beyond.